Advantages of mizoribine over azathioprine in combination therapy with cyclosporine for renal transplantation.
Department of Surgery, University of Tokyo, Japan.
K
K
Mita
N
N
Akiyama
T
T
Nagao
H
H
Sugimoto
S
S
Inoue
T
T
Osakabe
Y
Y
Nakayama
K
K
Yokota
K
K
Sato
H
H
Uchida
D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003524:Cyclosporins / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D008875:Middle Aged; D012263:Ribonucleosides / Q000627:therapeutic use*
D003524:Cyclosporins; D007166:Immunosuppressive Agents; D012263:Ribonucleosides; C010052:mizoribine; D001379:Azathioprine